Role of echocardiography in the diagnosis and management of asymptomatic severe aortic stenosis

Expert Review of Cardiovascular Therapy

Volumn 6, Issue 2, 2008, Pages 223-233

  Dal Bianco, Jacob P ^a   Sengupta, Partho P ^b   Khandheria, Bijoy K ^b  

^a MAYO CLINIC ROCHESTER   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Aortic stenosis; Aortic valve; Asymptomatic; Calcification; Doppler; Echocardiography; Left ventricle; Sclerosis; Valve replacement

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AORTA STENOSIS; AORTA VALVE REPLACEMENT; ATHEROSCLEROSIS; BLOOD VESSEL CALCIFICATION; DIAGNOSTIC IMAGING; DISEASE COURSE; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; DOPPLER TISSUE IMAGING; ECHOCARDIOGRAPHY; EVIDENCE BASED MEDICINE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MOVEMENT; HUMAN; HYPERLIPIDEMIA; MOLECULAR IMAGING; PATHOPHYSIOLOGY; PHARMACOLOGIC STRESS TESTING; PROGNOSIS; REVIEW; RISK FACTOR; SURVIVAL TIME; THREE DIMENSIONAL ECHOCARDIOGRAPHY; TREATMENT INDICATION; TWO DIMENSIONAL ECHOCARDIOGRAPHY; AORTA; AORTA VALVE STENOSIS; ECHOGRAPHY; HOSPITALIZATION; METHODOLOGY; PATHOLOGY; PRACTICE GUIDELINE; SCLEROSIS;

AORTA; AORTIC VALVE STENOSIS; ECHOCARDIOGRAPHY; GUIDELINES AS TOPIC; HUMANS; RISK FACTORS; SCLEROSIS; SEVERITY OF ILLNESS INDEX;

EID: 40149086877     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.6.2.223     Document Type: Review

References (102)

1. Stewart BF, Siscovick D, Lind BK et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J. Am. Coll. Cardiol. 29(3), 630-634 (1997).
2. Nkomo VT, Gardin JM, Skelton TN et al. Burden of valvular heart diseases: a population-based study. Lancet 368(9540), 1005-1011 (2006).
3. Cosmi JE, Kort S, Tunick PA et al. The risk of the development of aortic stenosis in patients with "benign" aortic valve thickening. Arch. Intern. Med. 162(20), 2345-2347 (2002).
4. Rosenhek R, Klaar U, Schemper M et al. Mild and moderate aortic stenosis. Natural history and risk stratification by echocardiography. Eur. Heart J. 25(3), 199-205 (2004).
5. Selzer A. Changing aspects of the natural history of valvular aortic stenosis. N. Engl. J. Med. 317(2), 91-98 (1987).
6. Dare AJ, Veinot JP, Edwards WD, Tazelaar HD, Schaff HV. New observations on the etiology of aortic valve disease: a surgical pathologic study of 236 cases from 1990. Hum. Pathol. 24(12), 1330-1338 (1993).
7. Roberts WC, Ko JM. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation 111(7), 920-925 (2005).
8. Agmon Y, Khandheria BK, Jamil Tajik A et al. Inflammation, infection, and aortic valve sclerosis; Insights from the Olmsted County (Minnesota) population. Atherosclerosis 174(2), 337-342 (2004).
9. Olsson M, Dalsgaard CJ, Haegerstrand A et al. Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves. J. Am. Coll. Cardiol. 23(5), 1162-1170 (1994).
10. Otto CM, Kuusisto J, Reichenbach DD, Gown AM, O'Brien KD. Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 90(2), 844-853 (1994).
11. O'Brien KD, Reichenbach DD, Marcovina SM et al. Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis. Arterioscler. Thromb. Vasc. Biol. 16(4), 523-532 (1996).
12. Mohler ER 3rd, Gannon F, Reynolds C et al. Bone formation and inflammation in cardiac valves. Circulation 103(11), 1522-1528 (2001).
13. Rajamannan NM, Sangiorgi G, Springett M et al. Experimental hypercholesterolemia induces apoptosis in the aortic valve. J Heart Value Dis. (10)(3), 371-374 (2001).
14. O'Brien KD, Shavelle DM, Caulfield MT et al. Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma. Circulation 106(17), 2224-2230 (2002).
15. Wallby L, Janerot-Sjoberg B, Steffensen T, Broqvist M. T lymphocyte infiltration in non-rheumatic aortic stenosis: a comparative descriptive study between tricuspid and bicuspid aortic valves. Heart 88(4), 348-351 (2002).
16. Rajamannan NM, Subramaniam M, Rickard D et al. Human aortic valve calcification is associated with an osteoblast phenotype. Circulation 107(17), 2181-2184 (2003).
17. Bonow RO, Carabello BA, Chatterjee K et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J. Am. Coll. Cardiol. 48(3), e1-e148 (2006).
18. Turina J, Hess O, Sepulcri F, Krayenbuehl HP. Spontaneous course of aortic valve disease. Eur. Heart J. 80(5), 471-483 (1987).
19. Horstkotte D, Loogen F. The natural history of aortic valve stenosis. Eur. Heart J. 9(Suppl. E), 57-64 (1988).
20. Kelly TA, Rothbart RM, Cooper CM et al. Comparison of outcome of asymptomatic to symptomatic patients older than 20 years of age with valvular aortic stenosis. Am. J. Cardiol. 61(1), 123-130 (1988).
21. Iivanainen AM, Lindroos M, Tilvis R, Heikkila J, Kupari M. Natural history of aortic valve stenosis of varying severity in the elderly. Am. J. Cardiol. 78(1), 97-101 (1996).
22. Lindblom D, Lindblom U, Qvist J, Lundstrom H. Long-term relative survival rates after heart valve replacement. J. Am. Coll. Cardiol. 15(3), 566-573 (1990).
23. Chapter 219. In: Harrison's Online. Kasper DL, Braunwald E, Fauci AS et al. (Eds). The McGraw-Hill Companies, NY, USA.
24. Pellikka PA, Sarano ME, Nishimura RA et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation 111(24), 3290-3295 (2005).
25. Baumgartner H. Aortic stenosis: medical and surgical management. Heart 91(11), 1483-1488 (2005).
26. Spann JF, Bove AA, Natarajan G, Kreulen T. Ventricular performance, pump function and compensatory mechanisms in patients with aortic stenosis. Circulation 62(3), 576-582 (1980).
27. Sasayama S, Ross J Jr, Franklin D et al. Adaptations of the left ventricle to chronic pressure overload. Circ. Res. 38(3), 172-178 (1976).
28. Krayenbuehl HP, Hess OM, Ritter M, Monrad ES, Hoppeler H. Left ventricular systolic function in aortic stenosis. Eur. Heart J. 9(Suppl. E), 19-23 (1988).
29. Otto CM, Pearlman AS, Gardner CL. Hemodynamic progression of aortic stenosis in adults assessed by Doppler, echocardiography. J. Am. Coll. Cardiol. 13(3), 545-550 (1989).
30. Roger VL, Tajik AJ, Bailey KR et al. Progression of aortic stenosis in adults: new appraisal using Doppler echocardiography. Am. Heart J. 119(2 Pt 1), 331-338 (1990).
31. Brener SJ, Duffy CI, Thomas JD, Stewart WJ. Progression of aortic stenosis in 394 patients: relation to changes in myocardial and mitral valve dysfunction. J. Am. Coll Cardiol. 25(2), 305-310 (1995).
32. Rosenhek R, Binder T, Porenta G et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N. Engl. J. Med. 343(9), 611-617 (2000).
33. Otto CM, Burwash IG, Legget ME et al. Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. Circulation 95(9), 2262-2270 (1997).
34. Pellikka PA, Nishimura RA, Bailey KR, Tajik AJ. The natural history of adults with asymptomatic, hemodynamically significant aortic stenosis. J. Am. Coll. Cardiol. 15(5), 1012-1017 (1990).
35. Munt B, Legget ME, Kraft CD et al. Physical examination in valvular aortic stenosis: correlation with stenosis severity and prediction of clinical outcome. Am. Heart J. 137(2), 298-306 (1999).
36. Cheitlin MD, Armstrong WF, Aurigemma GP et al. ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). J. Am. Soc. Echocardiogr. 16(10), 1091-1110 (2003).
37. Quinones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA. Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J. Am. Soc. Echocardiogr. 15(2), 167-184 (2002).
38. Otto CM. Valvular aortic stenosis: disease severity and timing of intervention. J. Am. Coll. Cardiol. 47(11), 2141-2151 (2006).
39. Bermejo J, Odreman R, Feijoo J et al. Clinical efficacy of Doppler-echocardiographic indices of aortic valve stenosis: a comparative test-based analysis of outcome. J. Am. Coll. Cardiol. 41(1), 142-151 (2003).
40. Alborino D, Hoffmann JL, Fournet PC, Bloch A. Value of exercise testing to evaluate the indication for surgery in asymptomatic patients with valvular aortic stenosis. J. Heart Valve Dis. 11(2), 204-209 (2002).
41. Otto CM, Pearlman AS, Kraft CD et al. Physiologic changes with maximal exercise in asymptomatic valvular aortic stenosis assessed by Doppler echocardiography. J. Am. Coll. Cardiol. 20(5), 1160-1167 (1992).
42. Clyne CA, Arrighi JA, Maron BJ et al. Systemic and left ventricular responses to exercise stress in asymptomatic patients with valvular aortic stenosis. Am. J. Cardiol. 68(15), 1469-1476 (1991).
43. Atwood JE, Kawanishi S, Myers J, Froelicher VF. Exercise testing in patients with aortic stenosis. Chest 93(5), 1083-1087 (1988).
44. Nylander E, Ekman I, Marklund T et al. Severe aortic stenosis in elderly patients. Br. Heart J. 55(5), 480-487 (1986).
45. Lancellotti P, Lebois F, Simon M et al. Prognostic importance of quantitative exercise Doppler echocardiography in asymptomatic valvular aortic stenosis. Circulation 112(9 Suppl.), 1377-1382 2005).
46. Amato MC, Moffa PJ, Werner KE, Ramires JA. Treatment decision in asymptomatic aortic valve stenosis: role of exercise testing. Heart 86(4), 381-386 (2001).
47. Das P, Rimington H, Chambers J. Exercise testing to stratify risk in aortic stenosis. Eur. Heart J. 26(13), 1309-1313 (2005).
48. Marechaux S, Ennezat PV, Lejemtel TH et al. Left ventricular response to exercise in aortic stenosis: an exercise echocardiographic study. Echocardiography 24(9), 955-959 (2007).
49. Monin JL, Quere JP, Monchi M et al. Low-gradient aortic stenosis: operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics. Circulation 108(3), 319-324 (2003).
50. Omar RZ, Ambler G, Royston P, Eliahoo J, Taylor KM. Cardiac surgery risk modeling for mortality: a review of current practice and suggestions for improvement. Ann. Thorac. Surg. 77(6), 2232-2237 (2004).
51. Iung B, Baron G, Butchart EG et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur. Heart J. 24(13), 1231-1243 (2003).
52. Kolh P, Lahaye L, Gerard P, Limet R. Aortic valve replacement in the octogenarians: perioperative outcome and clinical follow-up. Eur. J. Cardiothorac. Surg. 16(1), 68-73 (1999).
53. Kolh P, Kerzmann A, Lahaye L, Gerard P, Limet R. Cardiac surgery in octogenarians; peri-operative outcome and long-term results. Eur. Heart J. 22(14), 1235-1243 (2001).
54. Akins CW, Daggett WM, Vlahakes GJ et al. Cardiac operations in patients 80 years old and older. Ann. Thorac. Surg. 64(3), 606-614; discussion 614-605 (1997).
55. Kolh P, Kerzmann A, Honore C, Comte L, Limet R. Aortic valve surgery in octogenarians: predictive factors for operative and long-term results. Eur. J. Cardiothorac. Surg. 31(4), 600-606 (2007).
56. Bose AK, Aitchison JD, Dark JH. Aortic valve replacement in octogenarians. J. Cardiothorac. Surg. 2, 33 (2007).
57. Vahanian A, Baumgartner H, Bax J et al. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur. Heart J. 28(2), 230-268 (2007).
58. Douglas PS, Khandheria B, Stainback RF et al. ACCF/ASE/ACEP/ASNC/ SCAI/SCCT/SCMR 2007 appropriateness criteria for transthoracic and transesophageal echocardiography: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American Society of Echocardiography, American College of Emergency Physicians, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and the Society for Cardiovascular Magnetic Resonance. Endorsed by the American College of Chest Physicians and the Society of Critical Care Medicine. J. Am. Soc. Echocardiogr. 20(7), 787-805 (2007).
59. Rosenhek R, Binder T, Porenta G et al. Identification of high risk patients with severe, but asymptomatic aortic stenosis. Acta Med. Austriaca 28(1), 27-29 (2001).
60. Kadem L, Dumesnil JG, Rieu R et al. Impact of systemic hypertension on the assessment of aortic stenosis. Heart 91(3), 354-361 (2005).
61. Pibarot P, Dumesnil JG. Assessment of aortic stenosis severity: check the valve but don't forget the arteries! Heart 93(7), 780-782 (2007).
62. Rosenhek R, Rader F, Loho N et al. Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis. Circulation 110(10), 1291-1295 (2004).
63. Shavelle DM, Takasu J, Budoff MJ et al. HMG CoA reductase inhibitor (statin) and aortic valve calcium. Lancet 359(9312), 1125-1126 (2002).
64. Bellamy MF, Pellikka PA, Klarich KW, Tajik AJ, Enriquez-Sarano M. Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community. J. Am. Coll. Cardiol. 40(10), 1723-1730 (2002).
65. O'Brien KD, Probstfield A, Caulfield MT et al. Angiotensin-converting enzyme inhibitors and change in aortic valve calcium. Arch. Intern. Med. 165(8), 858-862 (2005).
66. Cowell SJ, Newby DE, Prescott RJ et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N. Engl. J. Med. 352(23), 2389-2397 (2005).
67. Moura LM, Ramos SF, Zamorano JL et al. Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis. J. Am. Coll Cardiol. 49(5), 554-561 (2007).
68. Hung J, Lang R, Flachskampf F et al. 3D echocardiography: a review of the current status and future directions. J. Am. Soc. Echocardiogr. 20(3), 213-233 (2007).
69. Ge S, Warner JG Jr, Abraham TP et al. Three-dimensional surface area of the aortic valve orifice by three-dimensional echocardiography: clinical validation of a novel index for assessment of aortic stenosis. Am Heart J. 136(6), 1042-1050 (1998).
70. Menzel T, Mohr-Kahaly S, Kolsch B et al. Quantitative assessment of aortic stenosis by three-dimensional echocardiography. J. Am. Soc. Echocardiogr. 10(3), 215-223 (1997).
71. Nanda NC, Roychoudhury D, Chung SM et al. Quantitative assessment of normal and stenotic aortic valve using transesophageal three-dimensional echocardiography. Echocardiography 11(6), 617-625 (1994).
72. Kasprzak JD, Nosir YF, Dall'Agata A et al. Quantification of the aortic valve area in three-dimensional echocardiographic data sets: analysis of orifice overestimation resulting from suboptimal cut-plane selection. Am. Heart J. 135(6 Pt 1), 995-1003 (1998).
73. Goland S, Trento A, Iida K et al. Assessment of aortic stenosis by three-dimensional echocardiography: an accurate and novel approach. Heart 93(7), 801-807 (2007).
74. Gilon D, Cape EG, Handschumacher MD et al. Effect of three-dimensional valve shape on the hemodynamics of aortic stenosis: three-dimensional echocardiographic stereolithography and patient studies. J. Am. Coll. Cardiol. 40(8), 1479-1486 (2002).
75. Huber D, Grimm J, Koch R, Krayenbuehl HP. Determinants of ejection performance in aortic stenosis. Circulation 64(1), 126-134 (1981).
76. Carabello BA, Green LH, Grossman W et al. Hemodynamic determinants of prognosis of aortic valve replacement in critical aortic stenosis and advanced congestive heart failure. Circulation 62(1), 42-48 (1980).
77. Gorcsan J 3rd, Gulati VK, Mandarino WA, Katz WE. Color-coded measures of myocardial velocity throughout the cardiac cycle by tissue Doppler imaging to quantify regional left ventricular function. Am. Heart J. 131(6), 1203-1213 (1996).
78. Gulati VK, Katz WE, Follansbee WP, Gorcsan J, 3rd. Mitral annular descent velocity by tissue Doppler echocardiography as an index of global left ventricular function. Am. J. Cardiol. 77(11), 979-984 (1996).
79. De Boeck BW, Cramer MJ, Oh JK, van der Aa RP, Jaarsma W. Spectral pulsed tissue Doppler imaging in diastole: a tool to increase our insight in and assessment of diastolic relaxation of the left ventricle. Am. Heart J. 146(3), 411-419 (2003).
80. Garcia-Fernandez MA, Azevedo J, Moreno M et al. Regional diastolic function in ischaemic heart disease using pulsed wave Doppler tissue imaging. Eur. Heart J. 20(7), 496-505 (1999).
81. Yu CM, Sanderson JE, Marwick TH, Oh JK. Tissue Doppler imaging a new prognosticator for cardiovascular diseases. J. Am. Coll. Cardiol. 49(19), 1903-1914 (2007).
82. Gilman G, Khandheria BK, Hagen ME et al. Strain rate and strain: a step-by-step approach to image and data acquisition. J. Am. Soc. Echocardiogr. 17(9), 1011-1020 (2004).
83. Bruch C, Stypmann J, Grude M et al. Tissue Doppler imaging in patients with moderate to severe aortic valve stenosis: clinical usefulness and diagnostic accuracy. Am. Heart J. 148(4), 696-702 (2004).
84. Giorgi D, Di Bello V, Talini E et al. Myocardial function in severe aortic stenosis before and after aortic valve replacement: a Doppler tissue imaging study. J. Am. Soc. Echocardiogr. 18(1), 8-14 (2005).
85. Galema TW, Yap SC, Geleijnse ML et al. Early detection of left ventricular dysfunction by Doppler tissue imaging and N-terminal pro-B-type natriuretic peptide in patients with symptomatic severe aortic stenosis. J. Am. Soc. Echocardiogr. (2007).
86. Van Pelt NC, Stewart RA, Legget ME et al Longitudinal left ventricular contractile dysfunction after exercise in aortic stenosis. Heart 93(6), 732-738 (2007).
87. Iwahashi N, Nakatani S, Kanzaki H et al. Acute improvement in myocardial function assessed by myocardial strain and strain rate after aortic valve replacement for aortic stenosis. J. Am. Soc. Echocardiogr. 19(10), 1238-1244 (2006).
88. Poulsen SH, Sogaard P, Nielsen-Kudsk JE, Egeblad H. Recovery of left ventricular systolic longitudinal strain after valve replacement in aortic stenosis and relation to natriuretic peptides. J. Am. Soc. Echocardiogr. 20(7), 877-884 (2007).
89. Stott DK, Marpole DG, Bristow JD, Kloster FE, Griswold HE. The role of left atrial transport in aortic and mitral stenosis. Circulation 41(6), 1031-1041 (1970).
90. Poh KK, Chan MY, Yang H et al. Prognostication of Valvular Aortic Stenosis Using Tissue Doppler Echocardiography: Underappreciated Importance of Late Diastolic Mitral Annular Velocity. J. Am. Soc. Echocardiogr. (2007).
91. Sengupta PP, Krishnamoorthy VK, Korinek J et al. Left ventricular form and function revisited: applied translational science to cardiovascular ultrasound imaging. J. Am. Soc. Echocardiogr. 20(5), 539-551 (2007).
92. Stuber M, Scheidegger MB, Fischer SE et al. Alterations in the local myocardial motion pattern in patients suffering from pressure overload due to aortic stenosis. Circulation 100(4), 361-368 (1999).
93. Nagel E, Stuber M, Burkhard B et al. Cardiac rotation and relaxation in patients with aortic valve stenosis. Eur. Heart J. 21(7), 582-589 (2000).
94. Biederman RW, Doyle M, Yamrozik J et al. Physiologic compensation is supranormal in compensated aortic stenosis: does it return to normal after aortic valve replacement or is it blunted by coexistent coronary artery disease? An intramyocardial magnetic resonance imaging study. Circulation 112(9 Suppl), 1429-436 (2005).
95. Van Der Toorn A, Barenbrug P, Snoep G et al. Transmural gradients of cardiac myofiber shortening in aortic valve stenosis patients using MRI tagging. Am. J. Physiol. Heart Circ. Physiol. 283(4), H1609-H1615 (2002).
96. Aikawa E, Nahrendorf M, Sosnovik D et al. Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. Circulation 115(3), 377-386 (2007).
97. Behm CZ, Lindner JR. Cellular and molecular imaging with targeted contrast ultrasound. Ultrasound Q. 22(1), 67-72 (2006).
98. Rychak JJ, Lindner JR, Ley K, Klibanov AL. Deformable gas-filled microbubbles targeted to P-selectin. J. Control Release 114(3), 288-299 (2006).
99. Kaufmann BA, Sanders JM, Davis C et al. Molecular imaging of inflammation in atherosclerosis with targeted ultrasound detection of vascular cell adhesion molecule-1. Circulation 116(3), 276-284 (2007).
100. Kaufmann BA, Lindner JR. Molecular imaging with targeted contrast ultrasound. Curr. Opin. Biotechnol. 18(1), 11-16 (2007).
101. Handke M, Jahnke C, Heinrichs G et al. New three-dimensional echocardiographic system using digital radiofrequency data - visualization and quantitative analysis of aortic valve dynamics with high resolution: methods, feasibility, and initial clinical experience. Circulation 107(23), 2876-2879 (2003).
102. Kennedy KD, Nishimura RA, Holmes DR Jr, Bailey KR. Natural history of moderate aortic stenosis. J. Am. Coll. Cardiol. 17(2), 313-319 (1991).